Provexis PLC focuses on the discovery, development, and commercialization of functional foods, medical foods, and dietary supplements, primarily through its patented Fruitflow technology. Fruitflow is a natural extract from tomatoes that has been shown to reduce the risk of aberrant blood clotting, contributing to cardiovascular health. The company generates revenue by selling Fruitflow as an ingredient to food, beverage, and dietary supplement manufacturers, and it has established partnerships with DSM Nutritional Products and BYHEALTH Co., Ltd. to expand its market reach, particularly in Europe and China.